FDA approves new drug for PAH
On Dec. 22, the U.S. Food and Drug Administration (FDA) approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH). Read more.
Web Exclusives
Metformin may have role in pre-eclampsia
A study in American Journal of Obstetrics and Gynecology reports that metformin may have the potential to prevent and treat pre-eclampsia. Read more and read…
FDA approves new drugs
·On Dec. 16, the U.S. Food and Drug Administration (FDA) approved Basaglar (insulin glargine injection), a long-acting human insulin analog to improve glycemic control…
FDA approves new drugs
· On Dec. 8, the U.S. Food and Drug Administration (FDA) approved: · Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years…
New guidelines for managing care of breast cancer survivors
The American Cancer Society and the American Society of Clinical Oncology have released a new Breast Cancer Survivorship Care Guideline to help breast cancer…
FDA approves new treatment for multiple myeloma
On Nov. 30, the U.S. Food and Drug Administration (FDA) approved Empliciti (elotuzumab) in combination with two other therapies to treat people with multiple…
False-positive mammograms may indicate increased risk for breast cancer later in life
Women with a history of a false-positive mammogram result may be at increased risk of developing breast cancer for up to 10 years after…
New arrangement of peptides boosts their potential as drugs
Arranging peptides as a densely packaged brush protects them from digestion and improves the potential for use as drugs, according to a study in…
Drug therapy effective in hepatitis C
A once daily drug combination of sofosbuvir-velpatasvir for 12 weeks resulted in sustained eradication of several genotypes of the hepatitis C virus in 99%…
Moderate coffee intake may be beneficial
Drinking coffee daily is associated with a lower risk of deaths from Type 2 diabetes, cardiovascular diseases, and neurological diseases in nonsmokers, according to…
Nearly half of patients with hepatitis C on Medicaid denied drug coverage
Nearly 50% of Medicaid patients infected with chronic hepatitis C whose doctors had prescribed newer, life-saving antiviral drugs were denied coverage to the therapies…
Experimental drug may stop cancer-induced cachexia
Data from a preclinical study show that AR-42, an experimental drug, may stop cachexia associated with advanced cancers and restore muscle health, according to…
FDA approves new drug for PAH
On Dec. 22, the U.S. Food and Drug Administration (FDA) approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH).…
Metformin may have role in pre-eclampsia
A study in American Journal of Obstetrics and Gynecology reports that metformin may have the potential to prevent and treat pre-eclampsia. Read…
FDA approves new drugs
·On Dec. 16, the U.S. Food and Drug Administration (FDA) approved Basaglar (insulin glargine injection), a long-acting human insulin analog to improve…
FDA approves new drugs
· On Dec. 8, the U.S. Food and Drug Administration (FDA) approved: · Vonvendi, von Willebrand factor (Recombinant), for use in adults…
New guidelines for managing care of breast cancer survivors
The American Cancer Society and the American Society of Clinical Oncology have released a new Breast Cancer Survivorship Care Guideline to help…
FDA approves new treatment for multiple myeloma
On Nov. 30, the U.S. Food and Drug Administration (FDA) approved Empliciti (elotuzumab) in combination with two other therapies to treat people…
False-positive mammograms may indicate increased risk for breast cancer later in life
Women with a history of a false-positive mammogram result may be at increased risk of developing breast cancer for up to 10…
New arrangement of peptides boosts their potential as drugs
Arranging peptides as a densely packaged brush protects them from digestion and improves the potential for use as drugs, according to a…
Drug therapy effective in hepatitis C
A once daily drug combination of sofosbuvir-velpatasvir for 12 weeks resulted in sustained eradication of several genotypes of the hepatitis C virus…
Moderate coffee intake may be beneficial
Drinking coffee daily is associated with a lower risk of deaths from Type 2 diabetes, cardiovascular diseases, and neurological diseases in nonsmokers,…
Nearly half of patients with hepatitis C on Medicaid denied drug coverage
Nearly 50% of Medicaid patients infected with chronic hepatitis C whose doctors had prescribed newer, life-saving antiviral drugs were denied coverage to…
Experimental drug may stop cancer-induced cachexia
Data from a preclinical study show that AR-42, an experimental drug, may stop cachexia associated with advanced cancers and restore muscle health,…
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.